These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 18778014

  • 1. [Ocular manifestations in patients with systemic lupus erythematosus and antiphospholipid syndrome].
    Ostanek L, Modrzejewska M, Bobrowska-Snarska D, Brzosko M.
    Pol Arch Med Wewn; 2007; 117 Suppl():18-23. PubMed ID: 18778014
    [Abstract] [Full Text] [Related]

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 3. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 4. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA.
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [Abstract] [Full Text] [Related]

  • 6. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
    Ong SG, Cheng HM, Soon SC, Goh E, Chow SK, Yeap SS.
    Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
    [Abstract] [Full Text] [Related]

  • 7. BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Picceli VF, Skare TL, Nisihara RM, Nass FR, Messias-Reason IT, Utiyama SR.
    Lupus; 2016 Apr; 25(4):412-7. PubMed ID: 26537423
    [Abstract] [Full Text] [Related]

  • 8. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

  • 9. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D, Teodorescu MR, Varga J, Teodorescu M.
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [Abstract] [Full Text] [Related]

  • 10. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E, Glidden DV, Elder ME.
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [Abstract] [Full Text] [Related]

  • 11. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A, Kickler TS, Petri M.
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [Abstract] [Full Text] [Related]

  • 12. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J, Cabral AR, Alarcón-Segovia D.
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [Abstract] [Full Text] [Related]

  • 13. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS, Khamashta MA, Atsumi T, Amengual O, Bertolaccini ML, D'Cruz D, Amft N, Swana GT, Hughes GR.
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [Abstract] [Full Text] [Related]

  • 14. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
    Ermakova NA, Alekberova ZS, Reshetniak TM, Kalashnikova LA, Kosheleva NM.
    Vestn Oftalmol; 2005 Nov; 121(5):31-6. PubMed ID: 16274063
    [Abstract] [Full Text] [Related]

  • 15. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus.
    Montehermoso A, Cervera R, Font J, Ramos-Casals M, García-carrasco M, Formiga F, Callejas JL, Jorfán M, Griñó MC, Ingelmo M.
    Semin Arthritis Rheum; 1999 Apr; 28(5):326-32. PubMed ID: 10342390
    [Abstract] [Full Text] [Related]

  • 16. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U, Yayla ME, Ateş A, Okatan İE, Yurteri EU, Torgutalp M, Keleşoğlu ABD, Turgay TM, Kınıklı G.
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [Abstract] [Full Text] [Related]

  • 17. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M, Duzgun N, Tunc SE, Tutkak H.
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [Abstract] [Full Text] [Related]

  • 18. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development].
    Fischer K, Brzosko M, Walecka A, Ostanek L, Sawicki M.
    Pol Arch Med Wewn; 2007 May; 117 Suppl():13-7. PubMed ID: 18778013
    [Abstract] [Full Text] [Related]

  • 19. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F, Spinelli FR, Alessandri C, Pacelli M, Ceccarelli F, Marocchi E, Montali A, Capozzi A, Buttari B, Profumo E, Sorice M, Arca M, Valesini G, Riganò R.
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [Abstract] [Full Text] [Related]

  • 20. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.